Physician profile
Matthew E Dahl
NPI 1679666556
$11,541.12
in general payments reported to CMS, 2019-2025
18 companies · $252 in 2025
The $252 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,270 · 2020: $6,225 · 2021: $188 · 2022: $230 · 2023: $123 · 2024: $252 · 2025: $252.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $627.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $627.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $6,036.75 | 2020 | |
| Ambu INC. | $4,000.00 | 2019 | |
| Stryker Corporation | $442.79 | 2019-2022 | |
| Genzyme Corporation | $396.36 | 2020-2025 | |
| Optinose US, INC. | $128.13 | 2019-2025 | |
| Glaxosmithkline, LLC. | $110.03 | 2021-2024 | Nucala |
| Smith+Nephew, INC. | $99.85 | 2025 | Tula |
| Regeneron Healthcare Solutions, INC. | $73.35 | 2021-2024 | Dupixent |
| Intersect Ent, INC. | $41.74 | 2021 | |
| Merck Sharp & Dohme LLC | $38.88 | 2021 | |
| Medtronic, INC. | $29.33 | 2022-2023 | Stealthstation S8 Platform |
| Biocryst US Sales Co., LLC | $27.43 | 2025 | Orladeyo |
| Integra Lifesciences Corporation | $23.60 | 2025 | Inspira Air, Acclarent Aera, Relieva Spinplus Nav |
| Allergan, INC. | $20.15 | 2021 | |
| Aerin Medical INC. | $19.83 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dilon Technologies, INC. | $18.84 | 2023 | Hemoblast Bellows |
| Acclarent, INC | $18.06 | 2020 | |
| Arbor Pharmaceuticals, INC. | $16.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Dahl listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.